Verastem Oncology (VSTM) Tops Q3 EPS by 8c

Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.71), $0.08 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg